HEADER TRANSPORT PROTEIN 30-AUG-22 8AWW
TITLE TRANSTHYRETIN CONJUGATED WITH A TAFAMIDIS DERIVATIVE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: TRANSTHYRETIN;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: ATTR,PREALBUMIN,TBPA;
COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: TTR, PALB;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS TTR, TAFAMIDIS, PROTEIN-DRUG CONJUGATES, DRUG DESIGN, CANCER
KEYWDS 2 THERAPY., TRANSPORT PROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR L.CEROFOLINI,K.VASA,E.BIANCONI,M.SALOBEHAJ,G.CAPPELLI,G.LICCIARDI,
AUTHOR 2 A.PEREZ-RAFOLS,L.D.PADILLA CORTES,S.ANTONACCI,D.RIZZO,E.RAVERA,
AUTHOR 3 V.CALDERONE,G.PARIGI,C.LUCHINAT,A.MACCHIARULO,S.MENICHETTI,M.FRAGAI
REVDAT 3 07-FEB-24 8AWW 1 REMARK
REVDAT 2 02-AUG-23 8AWW 1 JRNL
REVDAT 1 12-JUL-23 8AWW 0
JRNL AUTH L.CEROFOLINI,K.VASA,E.BIANCONI,M.SALOBEHAJ,G.CAPPELLI,
JRNL AUTH 2 A.BONCIANI,G.LICCIARDI,A.PEREZ-RAFOLS,L.PADILLA-CORTES,
JRNL AUTH 3 S.ANTONACCI,D.RIZZO,E.RAVERA,C.VIGLIANISI,V.CALDERONE,
JRNL AUTH 4 G.PARIGI,C.LUCHINAT,A.MACCHIARULO,S.MENICHETTI,M.FRAGAI
JRNL TITL COMBINING SOLID-STATE NMR WITH STRUCTURAL AND BIOPHYSICAL
JRNL TITL 2 TECHNIQUES TO DESIGN CHALLENGING PROTEIN-DRUG CONJUGATES.
JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 62 03202 2023
JRNL REFN ESSN 1521-3773
JRNL PMID 37276329
JRNL DOI 10.1002/ANIE.202303202
REMARK 2
REMARK 2 RESOLUTION. 1.60 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX 1.20.1_4487
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : ML
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.47
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360
REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2
REMARK 3 NUMBER OF REFLECTIONS : 31492
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.180
REMARK 3 R VALUE (WORKING SET) : 0.178
REMARK 3 FREE R VALUE : 0.203
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 1574
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 35.4700 - 3.5600 1.00 2942 154 0.1664 0.1735
REMARK 3 2 3.5600 - 2.8200 1.00 2832 149 0.1669 0.2058
REMARK 3 3 2.8200 - 2.4700 1.00 2783 146 0.1802 0.2038
REMARK 3 4 2.4700 - 2.2400 1.00 2774 146 0.1681 0.2125
REMARK 3 5 2.2400 - 2.0800 1.00 2721 144 0.1659 0.1646
REMARK 3 6 2.0800 - 1.9600 1.00 2771 145 0.1726 0.2085
REMARK 3 7 1.9600 - 1.8600 1.00 2742 145 0.1867 0.2260
REMARK 3 8 1.8600 - 1.7800 1.00 2736 144 0.2083 0.2613
REMARK 3 9 1.7800 - 1.7100 0.98 2660 140 0.2296 0.2765
REMARK 3 10 1.7100 - 1.6500 0.94 2580 136 0.2309 0.2554
REMARK 3 11 1.6500 - 1.6000 0.88 2377 125 0.2479 0.2413
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.10
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.150
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.450
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.78
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : NULL NULL
REMARK 3 ANGLE : NULL NULL
REMARK 3 CHIRALITY : NULL NULL
REMARK 3 PLANARITY : NULL NULL
REMARK 3 DIHEDRAL : NULL NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 8AWW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-SEP-22.
REMARK 100 THE DEPOSITION ID IS D_1292124507.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 03-NOV-21
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 5.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : SEALED TUBE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : BRUKER D8 QUEST
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.541
REMARK 200 MONOCHROMATOR : GRAPHITE
REMARK 200 OPTICS : MIRRORS
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : BRUKER PHOTON III
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : XSCALE
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31504
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600
REMARK 200 RESOLUTION RANGE LOW (A) : 35.470
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2
REMARK 200 DATA REDUNDANCY : 12.20
REMARK 200 R MERGE (I) : 0.08000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 22.2000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66
REMARK 200 COMPLETENESS FOR SHELL (%) : 88.6
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : 0.90000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.000
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: MOLREP
REMARK 200 STARTING MODEL: 3TCT
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 47.39
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 1.4 M SODIUM CITRATE, PH 5.5, VAPOR
REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z
REMARK 290 3555 -X+1/2,Y+1/2,-Z
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 21.74000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.67000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.74000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.67000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 7720 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 18910 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -41.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -43.48000
REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000
REMARK 375
REMARK 375 SPECIAL POSITION
REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS
REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL
REMARK 375 POSITIONS.
REMARK 375
REMARK 375 ATOM RES CSSEQI
REMARK 375 C16 OIT A 201 LIES ON A SPECIAL POSITION.
REMARK 375 C17 OIT A 201 LIES ON A SPECIAL POSITION.
REMARK 375 C21 OIT A 201 LIES ON A SPECIAL POSITION.
REMARK 375 C17 OIT B 201 LIES ON A SPECIAL POSITION.
REMARK 375 HOH A 344 LIES ON A SPECIAL POSITION.
REMARK 375 HOH B 377 LIES ON A SPECIAL POSITION.
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 PRO A 125
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 O HOH A 392 O HOH A 393 2.04
REMARK 500 O HOH B 309 O HOH B 339 2.06
REMARK 500 O HOH B 302 O HOH B 368 2.09
REMARK 500 O HOH A 304 O HOH A 397 2.12
REMARK 500 OE1 GLU B 72 O HOH B 301 2.13
REMARK 500 O HOH A 308 O HOH A 398 2.14
REMARK 500 O HOH B 329 O HOH B 410 2.16
REMARK 500 O HOH A 341 O HOH A 400 2.17
REMARK 500 O HOH A 388 O HOH A 402 2.18
REMARK 500 O HOH B 338 O HOH B 379 2.18
REMARK 500 O HOH B 310 O HOH B 375 2.19
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 O HOH A 322 O HOH A 398 4555 2.00
REMARK 500 O HOH B 400 O HOH B 411 4454 2.09
REMARK 500 O HOH A 315 O HOH A 318 4455 2.13
REMARK 500 O HOH B 302 O HOH B 306 4554 2.14
REMARK 500
REMARK 500 REMARK: NULL
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 3TCT RELATED DB: PDB
REMARK 900 STRUCTURE OF WILD-TYPE TTR IN COMPLEX WITH TAFAMIDIS
DBREF 8AWW A 10 125 UNP P02766 TTHY_HUMAN 30 145
DBREF 8AWW B 10 125 UNP P02766 TTHY_HUMAN 30 145
SEQRES 1 A 116 CYS PRO LEU MET VAL LYS VAL LEU ASP ALA VAL ARG GLY
SEQRES 2 A 116 SER PRO ALA ILE ASN VAL ALA VAL HIS VAL PHE ARG LYS
SEQRES 3 A 116 ALA ALA ASP ASP THR TRP GLU PRO PHE ALA SER GLY LYS
SEQRES 4 A 116 THR SER GLU SER GLY GLU LEU HIS GLY LEU THR THR GLU
SEQRES 5 A 116 GLU GLU PHE VAL GLU GLY ILE TYR LYS VAL GLU ILE ASP
SEQRES 6 A 116 THR LYS SER TYR TRP LYS ALA LEU GLY ILE SER PRO PHE
SEQRES 7 A 116 HIS GLU HIS ALA GLU VAL VAL PHE THR ALA ASN ASP SER
SEQRES 8 A 116 GLY PRO ARG ARG TYR THR ILE ALA ALA LEU LEU SER PRO
SEQRES 9 A 116 TYR SER TYR SER THR THR ALA VAL VAL THR ASN PRO
SEQRES 1 B 116 CYS PRO LEU MET VAL LYS VAL LEU ASP ALA VAL ARG GLY
SEQRES 2 B 116 SER PRO ALA ILE ASN VAL ALA VAL HIS VAL PHE ARG LYS
SEQRES 3 B 116 ALA ALA ASP ASP THR TRP GLU PRO PHE ALA SER GLY LYS
SEQRES 4 B 116 THR SER GLU SER GLY GLU LEU HIS GLY LEU THR THR GLU
SEQRES 5 B 116 GLU GLU PHE VAL GLU GLY ILE TYR LYS VAL GLU ILE ASP
SEQRES 6 B 116 THR LYS SER TYR TRP LYS ALA LEU GLY ILE SER PRO PHE
SEQRES 7 B 116 HIS GLU HIS ALA GLU VAL VAL PHE THR ALA ASN ASP SER
SEQRES 8 B 116 GLY PRO ARG ARG TYR THR ILE ALA ALA LEU LEU SER PRO
SEQRES 9 B 116 TYR SER TYR SER THR THR ALA VAL VAL THR ASN PRO
HET OIT A 201 27
HET OIT B 201 27
HETNAM OIT ~{N}-(6-AZANYLHEXYL)-2-[3,5-BIS(CHLORANYL)PHENYL]-1,3-
HETNAM 2 OIT BENZOXAZOLE-6-CARBOXAMIDE
HETSYN OIT TAFAMIDIS DERIVATIVE
FORMUL 3 OIT 2(C20 H21 CL2 N3 O2)
FORMUL 5 HOH *228(H2 O)
HELIX 1 AA1 ASP A 74 LEU A 82 1 9
HELIX 2 AA2 ASP B 74 LEU B 82 1 9
SHEET 1 AA1 8 SER A 23 PRO A 24 0
SHEET 2 AA1 8 LEU A 12 ASP A 18 -1 N ASP A 18 O SER A 23
SHEET 3 AA1 8 ARG A 104 SER A 112 1 O LEU A 111 N LEU A 17
SHEET 4 AA1 8 SER A 115 THR A 123 -1 O SER A 115 N SER A 112
SHEET 5 AA1 8 SER B 115 THR B 123 -1 O TYR B 116 N THR A 118
SHEET 6 AA1 8 ARG B 104 SER B 112 -1 N SER B 112 O SER B 115
SHEET 7 AA1 8 LEU B 12 ASP B 18 1 N MET B 13 O ILE B 107
SHEET 8 AA1 8 SER B 23 PRO B 24 -1 O SER B 23 N ASP B 18
SHEET 1 AA2 8 GLU A 54 LEU A 55 0
SHEET 2 AA2 8 LEU A 12 ASP A 18 -1 N VAL A 14 O LEU A 55
SHEET 3 AA2 8 ARG A 104 SER A 112 1 O LEU A 111 N LEU A 17
SHEET 4 AA2 8 SER A 115 THR A 123 -1 O SER A 115 N SER A 112
SHEET 5 AA2 8 SER B 115 THR B 123 -1 O TYR B 116 N THR A 118
SHEET 6 AA2 8 ARG B 104 SER B 112 -1 N SER B 112 O SER B 115
SHEET 7 AA2 8 LEU B 12 ASP B 18 1 N MET B 13 O ILE B 107
SHEET 8 AA2 8 GLU B 54 LEU B 55 -1 O LEU B 55 N VAL B 14
SHEET 1 AA3 8 TRP A 41 LYS A 48 0
SHEET 2 AA3 8 ALA A 29 LYS A 35 -1 N VAL A 32 O ALA A 45
SHEET 3 AA3 8 GLY A 67 ILE A 73 -1 O GLU A 72 N HIS A 31
SHEET 4 AA3 8 HIS A 88 ALA A 97 -1 O ALA A 91 N ILE A 73
SHEET 5 AA3 8 HIS B 88 ALA B 97 -1 O VAL B 94 N GLU A 89
SHEET 6 AA3 8 GLY B 67 ILE B 73 -1 N ILE B 73 O ALA B 91
SHEET 7 AA3 8 ALA B 29 LYS B 35 -1 N HIS B 31 O GLU B 72
SHEET 8 AA3 8 TRP B 41 LYS B 48 -1 O ALA B 45 N VAL B 32
CRYST1 43.480 85.340 63.790 90.00 90.00 90.00 P 21 21 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.022999 0.000000 0.000000 0.00000
SCALE2 0.000000 0.011718 0.000000 0.00000
SCALE3 0.000000 0.000000 0.015676 0.00000